Organon (OGN) Gross Margin (2020 - 2026)

Organon (OGN) recorded quarterly Gross Margin of 53.63% in Q1 2026, up 9.07% quarter-over-quarter from 49.17% in Q4 2025, and down 195.0% on a YoY basis from 56.45% in Q1 2025.

Organon (OGN) Gross Margin (2020 - 2026) Analysis & Trends

Organon's Gross Margin history runs 7 years deep, the most recent figure standing at 53.63% for Q1 2026.

  • In Q1 2026, Gross Margin fell 195.0% year-over-year to 53.63%; the TTM figure through Mar 2026 stood at 52.82% (down 437.0% YoY), while the FY2025 annual figure was 53.3%, down 472.0% from the prior year.
  • Gross Margin was 53.63% for Q1 2026 at Organon, up from 49.17% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 64.2% in Q1 2022 to a low of 49.17% in Q4 2025.
  • Historically, Gross Margin has averaged 58.2% across 5 years, with a median of 58.43% in 2024.
  • The sharpest annual moves came in 2022 and 2025: Gross Margin jumped 344 bps in 2022, then sank 711 bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 60.0% in 2022, then fell by 5 bps to 57.26% in 2023, then decreased by 2 bps to 56.28% in 2024, then decreased by 13 bps to 49.17% in 2025, then increased by 9 bps to 53.63% in 2026.
  • The last three Gross Margin figures came in at 53.63% (Q1 2026), 49.17% (Q4 2025), and 53.5% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Gsk 92,134,969.93 Bn 92,134,964.97 Bn 7.76 Bn 75.42%
2 Eli Lilly 1,027.45 Bn 1,022.17 Bn 16.22 Bn 81.93%
3 Johnson & Johnson 559.08 Bn 537.03 Bn 15.96 Bn 66.31%
4 AbbVie 394.75 Bn 385.40 Bn 10.78 Bn 71.88%
5 Merck 295.12 Bn 289.47 Bn 12.09 Bn 74.24%
6 Amgen 186.65 Bn 174.61 Bn 5.87 Bn 68.16%
7 Gilead Sciences 159.22 Bn 151.50 Bn 5.52 Bn 79.24%
8 Pfizer 146.00 Bn 133.23 Bn -1.21 Bn -51.69%
9 Bristol Myers Squibb 113.22 Bn 102.77 Bn 8.07 Bn 70.22%
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 53.63%

Historic Data

Download Data
DateValue
Mar 31, 2026 53.63%
Dec 31, 2025 49.17%
Sep 30, 2025 53.50%
Jun 30, 2025 54.83%
Mar 31, 2025 55.58%
Dec 31, 2024 56.28%
Sep 30, 2024 58.34%
Jun 30, 2024 58.43%
Mar 31, 2024 59.00%
Dec 31, 2023 57.26%
Sep 30, 2023 59.71%
Jun 30, 2023 60.20%
Mar 31, 2023 62.29%
Dec 31, 2022 60.00%
Sep 30, 2022 64.15%
Jun 30, 2022 62.90%
Mar 31, 2022 64.20%
Dec 31, 2021 62.63%
Sep 30, 2021 61.94%
Jun 30, 2021 63.45%